Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)

Authors: Hidekazu Hirano, Naoki Takahashi, Yusuke Amanuma, Nobumi Suzuki, Daisuke Takahari, Takeshi Kawakami, Chie Kudo-Saito, Kengo Nagashima, Narikazu Boku, Ken Kato, Hirokazu Shoji

Source: BMC Cancer, Vol 25, Iss 1, Pp 1-8 (2025)

Subject Terms: Gastric cancer, Nanoparticle albumin-bound paclitaxel, Ramucirumab, Nivolumab, Immunotherapy beyond progression, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/ddf305482ce843bb8eecad746c210735

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as induction chemotherapy regimen for hypopharyngeal cancer

Authors: Cailing Jiang, Yulan Liu, Yunyan Mo, Lieyin Xu, Lin Zhu, Zhenya Li, Shengyuan Xu, Xi Qin, Guangteng Wu, Mafei Kang, Xiaosong He, Feng Xue

Source: Frontiers in Oncology, Vol 15 (2025)

Subject Terms: hypopharyngeal cancer, induction chemotherapy, nanoparticle albumin-bound paclitaxel, tegafur/gimeracil/oteracil, progression-free survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2025.1504658/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/f5f7fbc8f4b844f485f13d28c0267a51

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III–IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study

Authors: Lina Yin, Wei Jiang, Shuai Liu, Yi Fu, Lin Zhou, Xuan Pei, Shuang Ye, Wenbin Shen, Huijuan Yang, Boer Shan

Source: BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)

Subject Terms: Nanoparticle albumin-bound paclitaxel, Carboplatin, Stages III–IV, Unresectable ovarian cancer, Phase Ib/II study, Neoadjuvant treatment, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1741-7015

Access URL: https://doaj.org/article/b1f4c536d6d54eba85e05685b2d3d915

Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review

Authors: Pingchuan Ma, Guanru Wang, Ke Men, Chunjie Li, Ning Gao, Longjiang Li

Source: Nano TransMed, Vol 3, Iss , Pp 100036- (2024)

Subject Terms: Nanoparticle, Cancer treatment, Nanoparticle albumin-bound-paclitaxel, Nanomedicine, Medical technology, R855-855.5, Biotechnology, TP248.13-248.65, Medicine

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2790676024000074; https://doaj.org/toc/2790-6760

Access URL: https://doaj.org/article/2f268e10cfdc432aa62ae405fee9db19

Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer

Authors: Hiroaki Yamane, Tomoko Itagaki, Keiko Kajitani, Yuji Koura, Yoshiharu Kawabuchi, Masahiro Ohara

Source: Case Reports in Oncology, Vol 16, Iss 1, Pp 1121-1128 (2023)

Subject Terms: atezolizumab, breast cancer, cystoid macular edema, nanoparticle albumin-bound paclitaxel, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://beta.karger.com/Article/FullText/533999; https://doaj.org/toc/1662-6575

Access URL: https://doaj.org/article/89e23381732642e28d53c169d2dcc5a4

Evaluation of nanoparticle albumin-bound paclitaxel loaded macrophages for glioblastoma treatment based on a microfluidic chip

Authors: Zuorun Xie, Junyi Ye, Xinghua Gao, Hang Chen, Maosong Chen, Jiangfang Lian, Jingyun Ma, Hongcai Wang

Source: Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)

Subject Terms: microfluidic chip, glioblastoma, macrophage-based carrier, drug delivery, nanoparticle albumin-bound paclitaxel, Biotechnology, TP248.13-248.65

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fbioe.2024.1361682/full; https://doaj.org/toc/2296-4185

Access URL: https://doaj.org/article/e69c94ce71314d459e44d92edfd92c7c

Efficacy and safety of nanoparticle albumin-bound paclitaxel in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials and observational studies

Authors: Suwannasom, Nittiya ^a, Sriaksorn, Netsai ^a, Thepmalee, Chutamas ^a, Thephinlap, Chonthida ^a, Tanamatayarat, Patcharawan ^{b, c}, Khoothiam, Krissana ^d, Bäuemler, Hans ^e, Na-Ek, Nat ^{f, g, ∗}

Source: In Heliyon November 2023 9(11)

Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma

Authors: Hui Jiang, Qiaoqiao Li, Baoqing Chen, Mian Xi, Kanjiebubi Makelike, Shiliang Liu, Yonghong Hu, Yujia Zhu

Source: Cancer Medicine, Vol 12, Iss 14, Pp 15187-15198 (2023)

Subject Terms: dose escalation, esophageal squamous cell carcinoma, nanoparticle albumin‐bound‐paclitaxel, phase I study, radiotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/4fe0fa39b65d495c92d2f8902825346e

The efficacy and safety of nanoparticle albumin bound‐paclitaxel‐based regimen as second‐ or third‐line treatment in patients with advanced esophageal squamous cell carcinoma

Authors: Dao Xin, Yan Song, Lan Mu, Bo Zhang, Ling Qi, Jing Gao, Xingyuan Wang, Jianping Xu, Tao Qu, Jing Huang

Source: Thoracic Cancer, Vol 14, Iss 15, Pp 1392-1397 (2023)

Subject Terms: chemotherapy, esophageal squamous cell carcinoma, immunotherapy, nanoparticle albumin bound‐paclitaxel, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

Access URL: https://doaj.org/article/f70e0018fafb4473bafc61042dd1b37d

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

Authors: Zhichao Tian, Shuping Dong, Yang Yang, Shilei Gao, Yonghao Yang, Jinpo Yang, Peng Zhang, Xin Wang, Weitao Yao

Source: BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)

Subject Terms: Nanoparticle albumin-bound paclitaxel, PD-1 inhibitor, Programmed cell death protein 1, Sintilimab, Soft tissue sarcoma, Angiosarcoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/565b637b905e42a695d23df1635be373

Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

Authors: Junji Tsurutani, Fumikata Hara, Masahiro Kitada, Masato Takahashi, Yuichiro Kikawa, Hiroaki Kato, Eiko Sakata, Yoichi Naito, Yoshie Hasegawa, Tsuyoshi Saito, Tsutomu Iwasa, Naruto Taira, Tsutomu Takashima, Kosuke Kashiwabara, Tomohiko Aihara, Hirofumi Mukai

Source: Breast, Vol 55, Iss , Pp 63-68 (2021)

Subject Terms: Nab-paclitaxel, Nanoparticle albumin–bound paclitaxel, Metastatic breast cancer, Solvent-base paclitaxel, Chemotherapy-induced peripheral neuropathy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S0960977620302319; https://doaj.org/toc/1532-3080

Access URL: https://doaj.org/article/47ae3af95d7143318f7fa81b47457151

Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes

Authors: Sei-ichiro Motegi, Mai Ishikawa, Akiko Sekiguchi, Osamu Ishikawa

Source: Case Reports in Dermatology, Vol 11, Iss 3, Pp 273-277 (2019)

Subject Terms: nanoparticle albumin-bound paclitaxel, gemcitabine, scleroderma, acanthosis nigricans, Dermatology, RL1-803

File Description: electronic resource

Relation: https://www.karger.com/Article/FullText/503271; https://doaj.org/toc/1662-6567

Access URL: https://doaj.org/article/90169cad0ded499da893f4ebedda02db

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer

Authors: Md Sazzad Hassan, Nicholas Cwidak, Chloe Johnson, Silvio Däster, Serenella Eppenberger-Castori, Niranjan Awasthi, Jun Li, Margaret A. Schwarz, Urs von Holzen

Source: Frontiers in Pharmacology, Vol 12 (2021)

Subject Terms: esophageal cancer, c-Myc, flavopiridol, nanoparticle albumin-bound paclitaxel, BMS-754807, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.746385/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/f5751934a2b2441c9e8d93a1588ab9b7

The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic BRCA2 Mutation: A Case Report

Authors: Xiaozhun Huang, Chunling Wang, Teng Ma, Zhangkan Huang, Houhong Zhou, Lin Xu, Renjie Zhang, Jianjun Zhao, Yefan Zhang, Zhen Huang, Lin Shao, Yang Wang, Fan Yang, Xu Che

Source: Frontiers in Oncology, Vol 11 (2021)

Subject Terms: pancreatic squamous cell carcinoma, cisplatin, nanoparticle albumin-bound paclitaxel, BRCA2 mutation, overall survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.585983/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/19bd46deff264e84909af5fffe17a889

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer

Authors: Yuki Nakatani, Aya Nakaya, Takayasu Kurata, Takashi Yokoi, Yuki Takeyasu, Maiko Niki, Kayoko Kibata, Naoko Satsutani, Makoto Ogata, Takayuki Miyara, Shosaku Nomura

Source: Case Reports in Oncology, Vol 10, Iss 2, Pp 683-688 (2017)

Subject Terms: Interstitial lung disease, Nanoparticle albumin-bound paclitaxel, Non-small cell lung cancer, Single-agent treatment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.karger.com/Article/FullText/479148; https://doaj.org/toc/1662-6575

Access URL: https://doaj.org/article/d17b506364734148a72cd6f0d3df33a1

Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of Vater

Authors: Markus Kapp, Aleksander Kosmala, Stefan Kircher, Verena Luber, Volker Kunzmann

Source: Case Reports in Oncology, Vol 9, Iss 1, Pp 15-24 (2016)

Subject Terms: Adenocarcinoma of the ampulla of Vater, Intestinal-type adenocarcinoma, Pancreatobiliary type, FOLFOX, FOLFIRI, Gemcitabine, Nanoparticle albumin-bound paclitaxel, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.karger.com/Article/FullText/443304; https://doaj.org/toc/1662-6575

Access URL: https://doaj.org/article/407d69c3006e4ab79fdb97c873de7453

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.